| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RS domain binding | 1.09e-04 | 8 | 40 | 2 | GO:0050733 | |
| GeneOntologyBiologicalProcess | RNA splicing | ARL6IP4 TRA2A ACIN1 RSRP1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 RSRC1 CCNL1 SON ZRANB2 | 6.13e-22 | 502 | 41 | 20 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | ARL6IP4 TRA2A ACIN1 RSRP1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 SRSF8 RSRC1 SON PHRF1 ZRANB2 | 1.34e-19 | 551 | 41 | 19 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | TRA2A ACIN1 RSRP1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 SRSF8 RSRC1 SON | 1.23e-16 | 358 | 41 | 15 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | TRA2A ACIN1 RSRP1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 SRSF8 RSRC1 SON | 1.23e-16 | 358 | 41 | 15 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | TRA2A ACIN1 RSRP1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 SRSF8 RSRC1 SON | 1.45e-16 | 362 | 41 | 15 | GO:0000375 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | ARL6IP4 TRA2A ACIN1 RSRP1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 SRSF8 RSRC1 SON PHRF1 ZRANB2 | 1.65e-15 | 917 | 41 | 19 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP RNPS1 CLK3 THRAP3 CCNL1 SON | 4.64e-15 | 207 | 41 | 12 | GO:0043484 |
| GeneOntologyBiologicalProcess | RNA processing | ARL6IP4 TRA2A ACIN1 RSRP1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 RSRC1 CCNL1 SON PHRF1 ZRANB2 | 4.98e-15 | 1500 | 41 | 22 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP RNPS1 THRAP3 SON | 6.11e-14 | 129 | 41 | 10 | GO:0048024 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP RNPS1 THRAP3 SON | 4.77e-13 | 158 | 41 | 10 | GO:0050684 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.54e-11 | 28 | 41 | 6 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.93e-11 | 29 | 41 | 6 | GO:0050686 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 4.48e-11 | 33 | 41 | 6 | GO:0033119 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.68e-09 | 115 | 41 | 7 | GO:1903312 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.05e-08 | 79 | 41 | 6 | GO:0000380 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP RNPS1 THRAP3 SON | 1.17e-08 | 443 | 41 | 10 | GO:1903311 |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 5.65e-06 | 59 | 41 | 4 | GO:0000381 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 4.41e-05 | 99 | 41 | 4 | GO:0000245 | |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 1.07e-04 | 8 | 41 | 2 | GO:1990414 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 1.51e-04 | 52 | 41 | 3 | GO:0006376 | |
| GeneOntologyCellularComponent | nuclear speck | ARL6IP4 ACIN1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 PSKH1 SRSF8 RSRC1 CCNL1 SON | 4.17e-20 | 431 | 41 | 18 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear body | ARL6IP4 BLM ACIN1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 PSKH1 SRSF8 AHCTF1 RSRC1 CCNL1 SON | 4.75e-17 | 903 | 41 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | exon-exon junction complex | 7.44e-08 | 21 | 41 | 4 | GO:0035145 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRA2A ACIN1 SREK1 SRSF2 PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 AHCTF1 DMAP1 CCNL1 | 1.28e-06 | 1377 | 41 | 13 | GO:0140513 |
| GeneOntologyCellularComponent | ASAP complex | 2.25e-05 | 4 | 41 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | spliceosomal complex | 6.09e-05 | 215 | 41 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | mediator complex | 2.39e-03 | 37 | 41 | 2 | GO:0016592 | |
| Domain | RRM | 5.12e-10 | 217 | 39 | 9 | SM00360 | |
| Domain | RRM_dom | 7.62e-10 | 227 | 39 | 9 | IPR000504 | |
| Domain | - | 1.44e-09 | 244 | 39 | 9 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.35e-09 | 258 | 39 | 9 | IPR012677 | |
| Domain | RRM_1 | 9.46e-09 | 208 | 39 | 8 | PF00076 | |
| Domain | RRM | 2.07e-08 | 230 | 39 | 8 | PS50102 | |
| Domain | THRAP3_BCLAF1 | 1.27e-05 | 3 | 39 | 2 | PF15440 | |
| Domain | THRAP3_BCLAF1 | 1.27e-05 | 3 | 39 | 2 | IPR029199 | |
| Domain | G_patch | 1.45e-05 | 23 | 39 | 3 | SM00443 | |
| Domain | G_patch_dom | 1.45e-05 | 23 | 39 | 3 | IPR000467 | |
| Domain | G-patch | 1.45e-05 | 23 | 39 | 3 | PF01585 | |
| Domain | G_PATCH | 1.45e-05 | 23 | 39 | 3 | PS50174 | |
| Domain | SURP | 6.34e-05 | 6 | 39 | 2 | PS50128 | |
| Domain | Surp | 6.34e-05 | 6 | 39 | 2 | PF01805 | |
| Domain | SWAP | 6.34e-05 | 6 | 39 | 2 | SM00648 | |
| Domain | Surp | 6.34e-05 | 6 | 39 | 2 | IPR000061 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.83e-04 | 53 | 39 | 3 | IPR011047 | |
| Pathway | WP_MRNA_PROCESSING | 2.35e-12 | 126 | 29 | 9 | M39406 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.47e-12 | 212 | 29 | 10 | M14033 | |
| Pathway | WP_MRNA_PROCESSING | ACIN1 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SFSWAP RNPS1 BCLAF1 CLK3 PSKH1 SON | 3.15e-11 | 451 | 29 | 12 | MM15946 |
| Pathway | KEGG_SPLICEOSOME | 1.27e-10 | 127 | 29 | 8 | M2044 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.30e-10 | 283 | 29 | 10 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.29e-07 | 201 | 29 | 7 | MM15411 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 9.86e-07 | 724 | 29 | 10 | M16843 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.13e-06 | 277 | 29 | 7 | MM15414 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.01e-05 | 67 | 29 | 4 | M27694 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.49e-05 | 84 | 29 | 4 | M725 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.90e-04 | 612 | 29 | 7 | MM15547 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 4.82e-04 | 16 | 29 | 2 | M39484 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ARL6IP4 TRA2A ACIN1 RSRP1 SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 HIRIP3 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 5.08e-27 | 695 | 41 | 22 | 23602568 |
| Pubmed | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 8.91e-27 | 713 | 41 | 22 | 29802200 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | ARL6IP4 TRA2A ACIN1 NKTR CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 AHCTF1 SON PHRF1 ZRANB2 | 5.06e-26 | 259 | 41 | 17 | 30404004 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ARL6IP4 BLM TRA2A ACIN1 NKTR SRSF10 SRSF2 GPATCH8 CHERP SRSF4 HIRIP3 SRSF6 SFSWAP PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 SRSF8 AHCTF1 RSRC1 DMAP1 SON PHRF1 | 8.56e-26 | 1294 | 41 | 25 | 30804502 |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | BLM TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 THRAP3 SRSF8 SON | 8.24e-21 | 169 | 41 | 13 | 23084401 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ARL6IP4 TRA2A ACIN1 SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON ZRANB2 | 1.09e-20 | 807 | 41 | 19 | 22681889 |
| Pubmed | TRA2A ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 RSRC1 DMAP1 SON ZRANB2 | 2.68e-20 | 847 | 41 | 19 | 35850772 | |
| Pubmed | ARL6IP4 TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 6.71e-20 | 731 | 41 | 18 | 29298432 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BLM TRA2A ACIN1 SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 NIPBL BCLAF1 CLK3 THRAP3 DMAP1 SON ZRANB2 | 8.80e-20 | 1082 | 41 | 20 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BLM ACIN1 SRSF10 SRSF2 GPATCH8 HIRIP3 SRSF6 SFSWAP PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 CCNL1 SON PHRF1 ZRANB2 | 1.85e-19 | 774 | 41 | 18 | 15302935 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF2 SRSF4 PNN RNPS1 BCLAF1 PHIP THRAP3 SRSF8 SON | 1.02e-18 | 330 | 41 | 14 | 33301849 |
| Pubmed | TRA2A ACIN1 NKTR SRSF10 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 CCNL1 ZRANB2 | 3.00e-18 | 188 | 41 | 12 | 29721183 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | TRA2A ACIN1 TMEM131 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 SON | 3.58e-18 | 361 | 41 | 14 | 30344098 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 NIPBL PHIP THRAP3 SRSF8 AHCTF1 RSRC1 SON | 4.09e-18 | 1318 | 41 | 20 | 30463901 |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.48e-17 | 57 | 41 | 9 | 14559993 | |
| Pubmed | 3.80e-17 | 104 | 41 | 10 | 31365120 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BLM ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 NIPBL BCLAF1 PHIP THRAP3 AHCTF1 SON | 2.00e-16 | 954 | 41 | 17 | 36373674 |
| Pubmed | BLM TRA2A ACIN1 TMEM131 SRSF2 HIRIP3 PNN SRRM2 NIPBL BCLAF1 THRAP3 AHCTF1 DMAP1 SON | 3.61e-16 | 503 | 41 | 14 | 16964243 | |
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 3.12e-15 | 13 | 41 | 6 | 20516191 | |
| Pubmed | TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 THRAP3 SON | 3.37e-15 | 239 | 41 | 11 | 26641092 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | ARL6IP4 ACIN1 SRSF10 SRSF2 HIRIP3 PNN SRRM2 BCLAF1 THRAP3 ZRANB2 | 3.83e-15 | 163 | 41 | 10 | 22113938 |
| Pubmed | ARL6IP4 TRA2A ACIN1 SRSF4 HIRIP3 SFSWAP BCLAF1 CLK3 THRAP3 SRSF8 ZRANB2 | 5.79e-15 | 251 | 41 | 11 | 31076518 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BLM TRA2A ACIN1 SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF6 SFSWAP SRRM2 BCLAF1 THRAP3 DMAP1 SON ZRANB2 | 8.59e-15 | 989 | 41 | 16 | 36424410 |
| Pubmed | TRA2A ACIN1 GPATCH8 CHERP SRSF4 SRSF6 PNN BCLAF1 THRAP3 RSRC1 | 2.22e-13 | 244 | 41 | 10 | 29884807 | |
| Pubmed | 3.45e-13 | 255 | 41 | 10 | 15324660 | ||
| Pubmed | ARL6IP4 TRA2A ACIN1 SRSF10 PNN RNPS1 BCLAF1 THRAP3 SRSF8 ZRANB2 | 4.19e-13 | 260 | 41 | 10 | 36199071 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ACIN1 SRSF10 SREK1 SRSF2 GPATCH8 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SON ZRANB2 | 4.69e-13 | 1284 | 41 | 16 | 17353931 |
| Pubmed | ACIN1 SRSF2 GPATCH8 CHERP SRSF6 SFSWAP PNN SRRM2 BCLAF1 THRAP3 SON | 9.17e-13 | 399 | 41 | 11 | 35987950 | |
| Pubmed | 9.73e-13 | 115 | 41 | 8 | 17332742 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | TRA2A SRSF10 SRSF2 GPATCH8 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SON | 1.07e-12 | 714 | 41 | 13 | 28302793 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | TRA2A ACIN1 RSRP1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 | 1.39e-12 | 922 | 41 | 14 | 27609421 |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.50e-12 | 197 | 41 | 9 | 22365833 | |
| Pubmed | 2.66e-12 | 210 | 41 | 9 | 16565220 | ||
| Pubmed | 5.50e-12 | 80 | 41 | 7 | 25662211 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TRA2A ACIN1 SRSF10 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP THRAP3 SON | 5.67e-12 | 1024 | 41 | 14 | 24711643 |
| Pubmed | BLM ACIN1 SRSF2 CHERP SRSF4 PNN SRRM2 NIPBL PHIP AHCTF1 SON PHRF1 | 8.35e-12 | 653 | 41 | 12 | 22586326 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ARL6IP4 ACIN1 SRSF10 SRSF2 GPATCH8 PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 ZRANB2 | 1.03e-11 | 665 | 41 | 12 | 30457570 |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 2.49e-11 | 6 | 41 | 4 | 17361132 | |
| Pubmed | SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SFSWAP PNN RNPS1 CLK3 THRAP3 SRSF8 ZRANB2 | 2.71e-11 | 723 | 41 | 12 | 34133714 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRA2A ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP THRAP3 ZRANB2 | 3.33e-11 | 1425 | 41 | 15 | 30948266 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | BLM ACIN1 SREK1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 NIPBL THRAP3 | 5.26e-11 | 582 | 41 | 11 | 20467437 |
| Pubmed | BLM SRSF10 SREK1 SRSF2 GPATCH8 SFSWAP NIPBL CLK3 AHCTF1 RSRC1 DMAP1 CCNL1 SON PHRF1 ZRANB2 | 6.64e-11 | 1497 | 41 | 15 | 31527615 | |
| Pubmed | ARL6IP4 ACIN1 SREK1 CHERP SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 ZRANB2 | 1.84e-10 | 655 | 41 | 11 | 35819319 | |
| Pubmed | ARL6IP4 TRA2A ACIN1 SRSF10 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 | 1.99e-10 | 660 | 41 | 11 | 32780723 | |
| Pubmed | 2.34e-10 | 347 | 41 | 9 | 16033648 | ||
| Pubmed | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF2 SFSWAP RNPS1 BCLAF1 THRAP3 SRSF8 AHCTF1 RSRC1 SON | 2.66e-10 | 1371 | 41 | 14 | 36244648 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.08e-10 | 358 | 41 | 9 | 32460013 | |
| Pubmed | Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. | 5.45e-10 | 11 | 41 | 4 | 14729963 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 6.36e-10 | 258 | 41 | 8 | 37794589 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.01e-09 | 410 | 41 | 9 | 26949251 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.15e-09 | 170 | 41 | 7 | 16159877 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 4.83e-09 | 678 | 41 | 10 | 30209976 | |
| Pubmed | Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells. | 6.08e-09 | 4 | 41 | 3 | 14578391 | |
| Pubmed | The structure of the ASAP core complex reveals the existence of a Pinin-containing PSAP complex. | 6.08e-09 | 4 | 41 | 3 | 22388736 | |
| Pubmed | 6.31e-09 | 506 | 41 | 9 | 30890647 | ||
| Pubmed | 6.36e-09 | 19 | 41 | 4 | 25263594 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 7.43e-09 | 353 | 41 | 8 | 27545878 | |
| Pubmed | Identification and characterization of a novel serine-arginine-rich splicing regulatory protein. | 1.52e-08 | 5 | 41 | 3 | 10757789 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.41e-08 | 411 | 41 | 8 | 35182466 | |
| Pubmed | 2.44e-08 | 26 | 41 | 4 | 26586428 | ||
| Pubmed | SR proteins: a conserved family of pre-mRNA splicing factors. | 3.03e-08 | 6 | 41 | 3 | 1577277 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.06e-08 | 608 | 41 | 9 | 36089195 | |
| Pubmed | 3.13e-08 | 425 | 41 | 8 | 24999758 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | BLM ACIN1 SRSF10 SRSF6 PNN SRRM2 RNPS1 NIPBL PHIP THRAP3 AHCTF1 SON | 3.17e-08 | 1353 | 41 | 12 | 29467282 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 3.42e-08 | 430 | 41 | 8 | 38172120 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.49e-08 | 289 | 41 | 7 | 23752268 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 6.84e-08 | 180 | 41 | 6 | 30110629 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 7.00e-08 | 670 | 41 | 9 | 22990118 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 7.59e-08 | 477 | 41 | 8 | 31300519 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 8.75e-08 | 486 | 41 | 8 | 30940648 | |
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 8.99e-08 | 94 | 41 | 5 | 37468549 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | BLM TRA2A GPATCH8 CHERP PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 CCNL1 | 9.86e-08 | 1203 | 41 | 11 | 29180619 |
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 1.19e-07 | 38 | 41 | 4 | 19608861 | |
| Pubmed | 1.27e-07 | 9 | 41 | 3 | 19857271 | ||
| Pubmed | 1.39e-07 | 203 | 41 | 6 | 35012549 | ||
| Pubmed | ARL6IP4 ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 | 1.42e-07 | 1247 | 41 | 11 | 27684187 | |
| Pubmed | 1.52e-07 | 206 | 41 | 6 | 34185411 | ||
| Pubmed | 1.80e-07 | 42 | 41 | 4 | 35705031 | ||
| Pubmed | Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. | 1.81e-07 | 10 | 41 | 3 | 10983978 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.03e-07 | 361 | 41 | 7 | 26167880 | |
| Pubmed | 2.09e-07 | 1014 | 41 | 10 | 32416067 | ||
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 3.32e-07 | 12 | 41 | 3 | 15798186 | |
| Pubmed | 4.10e-07 | 244 | 41 | 6 | 30349055 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 4.41e-07 | 247 | 41 | 6 | 39238192 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 4.54e-07 | 130 | 41 | 5 | 35545047 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.61e-07 | 605 | 41 | 8 | 28977666 | |
| Pubmed | ARL6IP4 SREK1 SFSWAP SRRM2 RNPS1 PHIP AHCTF1 DMAP1 SON PHRF1 | 5.04e-07 | 1116 | 41 | 10 | 31753913 | |
| Pubmed | 7.12e-07 | 641 | 41 | 8 | 36057605 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 7.22e-07 | 59 | 41 | 4 | 16083285 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 7.25e-07 | 269 | 41 | 6 | 29511261 | |
| Pubmed | Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1. | 7.41e-07 | 270 | 41 | 6 | 24366813 | |
| Pubmed | 8.08e-07 | 274 | 41 | 6 | 34244482 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTMR3 BLM TRA2A TMEM131 SRSF10 SRSF4 SRRM2 EIF2AK3 PHIP AHCTF1 SON | 8.63e-07 | 1496 | 41 | 11 | 32877691 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 8.64e-07 | 148 | 41 | 5 | 32538781 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.74e-07 | 283 | 41 | 6 | 30585729 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.05e-06 | 154 | 41 | 5 | 16055720 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.35e-06 | 162 | 41 | 5 | 31363146 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 33095160 | ||
| Pubmed | Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. | 1.36e-06 | 2 | 41 | 2 | 23778535 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29112714 | ||
| Interaction | SNIP1 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 CLK3 THRAP3 SRSF8 AHCTF1 SON PHRF1 ZRANB2 | 4.78e-25 | 417 | 41 | 21 | int:SNIP1 |
| Interaction | SRPK2 interactions | ARL6IP4 TRA2A ACIN1 RSRP1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 HIRIP3 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 9.95e-25 | 717 | 41 | 24 | int:SRPK2 |
| Interaction | CLK2 interactions | TRA2A ACIN1 RSRP1 NKTR SRSF10 GPATCH8 SRSF4 HIRIP3 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON | 3.48e-24 | 195 | 41 | 17 | int:CLK2 |
| Interaction | SRSF11 interactions | ARL6IP4 TRA2A ACIN1 SRSF10 SREK1 SRSF2 GPATCH8 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SON ZRANB2 | 7.03e-24 | 203 | 41 | 17 | int:SRSF11 |
| Interaction | SRPK1 interactions | ARL6IP4 ACIN1 RSRP1 SRSF10 SREK1 SRSF2 CHERP SRSF4 HIRIP3 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 3.49e-22 | 477 | 41 | 20 | int:SRPK1 |
| Interaction | CLK3 interactions | TRA2A ACIN1 RSRP1 SRSF10 GPATCH8 CHERP SRSF4 HIRIP3 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 | 1.90e-21 | 220 | 41 | 16 | int:CLK3 |
| Interaction | SRSF4 interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 SON | 6.04e-21 | 300 | 41 | 17 | int:SRSF4 |
| Interaction | LUC7L interactions | TRA2A ACIN1 NKTR SRSF10 GPATCH8 CHERP SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 ZRANB2 | 8.95e-21 | 242 | 41 | 16 | int:LUC7L |
| Interaction | SRSF6 interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON PHRF1 | 3.71e-20 | 503 | 41 | 19 | int:SRSF6 |
| Interaction | SRSF7 interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON ZRANB2 | 6.17e-20 | 425 | 41 | 18 | int:SRSF7 |
| Interaction | RNPS1 interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 CLK3 THRAP3 CCNL1 SON | 6.17e-20 | 425 | 41 | 18 | int:RNPS1 |
| Interaction | NKAPD1 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF4 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 CCNL1 | 7.10e-20 | 161 | 41 | 14 | int:NKAPD1 |
| Interaction | SNRNP70 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 1.14e-18 | 984 | 41 | 22 | int:SNRNP70 |
| Interaction | DHX8 interactions | BLM NKTR GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 THRAP3 SON PHRF1 ZRANB2 | 8.22e-18 | 292 | 41 | 15 | int:DHX8 |
| Interaction | SAP18 interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 GPATCH8 SRSF6 PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 SON PHRF1 | 1.58e-17 | 305 | 41 | 15 | int:SAP18 |
| Interaction | DDX23 interactions | ACIN1 NKTR SRSF10 SREK1 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 PHRF1 ZRANB2 | 1.73e-17 | 480 | 41 | 17 | int:DDX23 |
| Interaction | U2AF2 interactions | TRA2A ACIN1 NKTR SRSF10 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON ZRANB2 | 1.18e-16 | 651 | 41 | 18 | int:U2AF2 |
| Interaction | SNRPC interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 GPATCH8 SRSF4 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 SON | 1.27e-16 | 440 | 41 | 16 | int:SNRPC |
| Interaction | CLK1 interactions | TRA2A SRSF10 SRSF2 SRSF4 HIRIP3 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 | 2.78e-16 | 219 | 41 | 13 | int:CLK1 |
| Interaction | MECP2 interactions | BLM TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 NIPBL BCLAF1 CLK3 THRAP3 SRSF8 DMAP1 SON ZRANB2 | 3.31e-16 | 1287 | 41 | 22 | int:MECP2 |
| Interaction | PNN interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 | 5.22e-16 | 302 | 41 | 14 | int:PNN |
| Interaction | ZC3H18 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF2 SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 RSRC1 SON ZRANB2 | 1.11e-15 | 877 | 41 | 19 | int:ZC3H18 |
| Interaction | MAGOH interactions | BLM TRA2A ACIN1 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 THRAP3 SRSF8 SON | 3.16e-15 | 264 | 41 | 13 | int:MAGOH |
| Interaction | LUC7L2 interactions | TRA2A ACIN1 SRSF10 SREK1 GPATCH8 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SRSF8 ZRANB2 | 4.55e-15 | 353 | 41 | 14 | int:LUC7L2 |
| Interaction | SNRPA interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF2 SRSF4 PNN SRRM2 RNPS1 BCLAF1 THRAP3 SRSF8 RSRC1 SON | 1.39e-14 | 482 | 41 | 15 | int:SNRPA |
| Interaction | RBM39 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 RSRC1 SON | 2.54e-14 | 1042 | 41 | 19 | int:RBM39 |
| Interaction | NUP43 interactions | ARL6IP4 BLM ACIN1 NKTR SRSF10 SREK1 GPATCH8 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP AHCTF1 SON PHRF1 | 3.04e-14 | 625 | 41 | 16 | int:NUP43 |
| Interaction | SNRNP40 interactions | BLM ACIN1 NKTR SRSF10 SREK1 GPATCH8 CHERP SRSF6 SFSWAP PNN SRRM2 BCLAF1 AHCTF1 RSRC1 SON PHRF1 | 4.08e-14 | 637 | 41 | 16 | int:SNRNP40 |
| Interaction | SREK1 interactions | ARL6IP4 SRSF10 SREK1 SRSF2 SRSF4 SRSF6 PNN RNPS1 THRAP3 SRSF8 ZRANB2 | 6.38e-14 | 183 | 41 | 11 | int:SREK1 |
| Interaction | DOT1L interactions | TRA2A ACIN1 SRSF10 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 THRAP3 AHCTF1 RSRC1 DMAP1 SON ZRANB2 | 9.12e-14 | 807 | 41 | 17 | int:DOT1L |
| Interaction | ZBTB2 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SRSF2 SRSF4 PNN RNPS1 BCLAF1 PHIP THRAP3 SRSF8 SON | 1.27e-13 | 450 | 41 | 14 | int:ZBTB2 |
| Interaction | RBBP6 interactions | TRA2A ACIN1 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 SON | 3.96e-13 | 216 | 41 | 11 | int:RBBP6 |
| Interaction | NR2C2 interactions | ARL6IP4 TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 NIPBL PHIP THRAP3 SRSF8 AHCTF1 RSRC1 SON | 4.10e-13 | 1403 | 41 | 20 | int:NR2C2 |
| Interaction | CSNK2A1 interactions | ARL6IP4 ACIN1 NKTR SRSF10 SREK1 SRSF2 HIRIP3 PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 DMAP1 CCNL1 PHRF1 ZRANB2 | 1.40e-12 | 956 | 41 | 17 | int:CSNK2A1 |
| Interaction | SSRP1 interactions | ARL6IP4 TRA2A ACIN1 SREK1 HIRIP3 SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP THRAP3 RSRC1 SON | 2.24e-12 | 685 | 41 | 15 | int:SSRP1 |
| Interaction | THRAP3 interactions | TRA2A ACIN1 SREK1 SRSF4 SRSF6 PNN RNPS1 NIPBL BCLAF1 CLK3 THRAP3 SRSF8 PHRF1 | 2.37e-12 | 443 | 41 | 13 | int:THRAP3 |
| Interaction | SMC5 interactions | BLM ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 NIPBL BCLAF1 PHIP THRAP3 AHCTF1 SON | 2.88e-12 | 1000 | 41 | 17 | int:SMC5 |
| Interaction | SF3A2 interactions | ACIN1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 | 5.08e-12 | 273 | 41 | 11 | int:SF3A2 |
| Interaction | PUF60 interactions | TRA2A SRSF10 SREK1 CHERP HIRIP3 PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 SON | 5.82e-12 | 369 | 41 | 12 | int:PUF60 |
| Interaction | EIF4A3 interactions | BLM TRA2A ACIN1 SRSF10 SRSF2 GPATCH8 SRSF4 SRSF6 PNN SRRM2 RNPS1 THRAP3 SON | 1.05e-11 | 499 | 41 | 13 | int:EIF4A3 |
| Interaction | CFAP20 interactions | 1.07e-11 | 91 | 41 | 8 | int:CFAP20 | |
| Interaction | ZC3H11A interactions | 1.30e-11 | 215 | 41 | 10 | int:ZC3H11A | |
| Interaction | ACIN1 interactions | ACIN1 SRSF4 SRSF6 PNN SRRM2 RNPS1 CLK3 THRAP3 SON PHRF1 ZRANB2 | 1.46e-11 | 301 | 41 | 11 | int:ACIN1 |
| Interaction | SRSF8 interactions | 1.96e-11 | 98 | 41 | 8 | int:SRSF8 | |
| Interaction | HDAC11 interactions | 2.00e-11 | 154 | 41 | 9 | int:HDAC11 | |
| Interaction | CPSF6 interactions | ARL6IP4 TRA2A ACIN1 RSRP1 NKTR SRSF10 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 SON | 2.03e-11 | 526 | 41 | 13 | int:CPSF6 |
| Interaction | UBR5 interactions | TRA2A ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SFSWAP RNPS1 CLK3 PSKH1 CCNL1 SON | 2.40e-11 | 533 | 41 | 13 | int:UBR5 |
| Interaction | GSPT2 interactions | 4.00e-11 | 107 | 41 | 8 | int:GSPT2 | |
| Interaction | MYCN interactions | ARL6IP4 TRA2A ACIN1 SRSF10 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 SON ZRANB2 | 4.01e-11 | 1373 | 41 | 18 | int:MYCN |
| Interaction | SRSF1 interactions | TRA2A SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SRRM2 RNPS1 CLK3 THRAP3 RSRC1 SON | 5.52e-11 | 570 | 41 | 13 | int:SRSF1 |
| Interaction | MEN1 interactions | TRA2A ACIN1 SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 DMAP1 SON | 5.87e-11 | 1029 | 41 | 16 | int:MEN1 |
| Interaction | KIF23 interactions | ARL6IP4 TRA2A ACIN1 SRSF10 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 BCLAF1 PHIP THRAP3 SRSF8 SON ZRANB2 | 6.04e-11 | 1031 | 41 | 16 | int:KIF23 |
| Interaction | RAD18 interactions | ARL6IP4 TRA2A ACIN1 SRSF4 HIRIP3 SFSWAP SRRM2 BCLAF1 CLK3 THRAP3 SRSF8 ZRANB2 | 6.97e-11 | 457 | 41 | 12 | int:RAD18 |
| Interaction | KIF20A interactions | ARL6IP4 BLM SRSF10 SRSF2 CHERP SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 THRAP3 SRSF8 AHCTF1 SON ZRANB2 | 8.14e-11 | 1052 | 41 | 16 | int:KIF20A |
| Interaction | CAMKV interactions | 8.83e-11 | 118 | 41 | 8 | int:CAMKV | |
| Interaction | PPP1CC interactions | TRA2A ACIN1 TMEM131 SRSF10 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 SON | 9.72e-11 | 738 | 41 | 14 | int:PPP1CC |
| Interaction | CIT interactions | TRA2A ACIN1 NKTR SRSF10 SREK1 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP THRAP3 SRSF8 AHCTF1 SON | 9.86e-11 | 1450 | 41 | 18 | int:CIT |
| Interaction | OBSL1 interactions | TRA2A ACIN1 SRSF10 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 PHIP THRAP3 SON ZRANB2 | 1.10e-10 | 902 | 41 | 15 | int:OBSL1 |
| Interaction | ELAVL2 interactions | 1.20e-10 | 188 | 41 | 9 | int:ELAVL2 | |
| Interaction | SRPK3 interactions | 1.31e-10 | 190 | 41 | 9 | int:SRPK3 | |
| Interaction | HMGB1 interactions | TRA2A ACIN1 NKTR SRSF10 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 CCNL1 ZRANB2 | 1.42e-10 | 486 | 41 | 12 | int:HMGB1 |
| Interaction | BRD3 interactions | ARL6IP4 TRA2A ACIN1 SREK1 SFSWAP PNN SRRM2 RNPS1 NIPBL PHIP DMAP1 SON | 1.71e-10 | 494 | 41 | 12 | int:BRD3 |
| Interaction | TRA2B interactions | TRA2A SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SRRM2 RNPS1 CLK3 SRSF8 ZRANB2 | 2.03e-10 | 385 | 41 | 11 | int:TRA2B |
| Interaction | JMJD6 interactions | 2.59e-10 | 205 | 41 | 9 | int:JMJD6 | |
| Interaction | SNRPB interactions | ARL6IP4 ACIN1 NKTR CHERP SRSF4 PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 SON | 2.87e-10 | 517 | 41 | 12 | int:SNRPB |
| Interaction | SRSF3 interactions | TRA2A SRSF10 SREK1 SRSF2 SRSF4 SRSF6 PNN SRRM2 RNPS1 CLK3 THRAP3 SRSF8 | 3.21e-10 | 522 | 41 | 12 | int:SRSF3 |
| Interaction | PABPC5 interactions | 3.91e-10 | 142 | 41 | 8 | int:PABPC5 | |
| Interaction | NFKBIL1 interactions | 7.01e-10 | 93 | 41 | 7 | int:NFKBIL1 | |
| Interaction | CD2BP2 interactions | 7.73e-10 | 232 | 41 | 9 | int:CD2BP2 | |
| Interaction | PRP4K interactions | 8.40e-10 | 329 | 41 | 10 | int:PRP4K | |
| Interaction | TRA2A interactions | 8.65e-10 | 330 | 41 | 10 | int:TRA2A | |
| Interaction | SF3B1 interactions | ACIN1 SRSF2 CHERP SRSF6 PNN SRRM2 RNPS1 NIPBL BCLAF1 THRAP3 RSRC1 SON | 8.91e-10 | 571 | 41 | 12 | int:SF3B1 |
| Interaction | CEBPB interactions | ARL6IP4 TRA2A ACIN1 SRSF10 SRSF2 GPATCH8 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 AHCTF1 DMAP1 SON | 9.04e-10 | 1443 | 41 | 17 | int:CEBPB |
| Interaction | LARP4B interactions | 1.04e-09 | 240 | 41 | 9 | int:LARP4B | |
| Interaction | LUZP4 interactions | 1.09e-09 | 99 | 41 | 7 | int:LUZP4 | |
| Interaction | SRRM2 interactions | TRA2A ACIN1 SRSF4 SRSF6 PNN SRRM2 RNPS1 CLK3 PHIP SON ZRANB2 | 1.39e-09 | 462 | 41 | 11 | int:SRRM2 |
| Interaction | SRRM1 interactions | 1.44e-09 | 348 | 41 | 10 | int:SRRM1 | |
| Interaction | SRSF5 interactions | TRA2A SRSF10 SREK1 SRSF2 CHERP SRSF4 SRSF6 SRRM2 CLK3 SRSF8 SON | 1.81e-09 | 474 | 41 | 11 | int:SRSF5 |
| Interaction | TNIP2 interactions | TRA2A ACIN1 RSRP1 SRSF2 CHERP SRSF4 SRSF6 SFSWAP PNN SRRM2 RNPS1 BCLAF1 CLK3 THRAP3 | 2.68e-09 | 952 | 41 | 14 | int:TNIP2 |
| Interaction | BMI1 interactions | TRA2A ACIN1 GPATCH8 CHERP SRSF4 SRSF6 RNPS1 BCLAF1 THRAP3 RSRC1 DMAP1 SON | 4.48e-09 | 659 | 41 | 12 | int:BMI1 |
| Interaction | PPIG interactions | 6.29e-09 | 127 | 41 | 7 | int:PPIG | |
| Interaction | SNRPA1 interactions | 7.35e-09 | 300 | 41 | 9 | int:SNRPA1 | |
| Interaction | PIP4K2A interactions | 1.08e-08 | 216 | 41 | 8 | int:PIP4K2A | |
| Interaction | SRRM4 interactions | 1.12e-08 | 37 | 41 | 5 | int:SRRM4 | |
| Interaction | DDX21 interactions | TRA2A ACIN1 CHERP SRSF4 SRSF6 PNN SRRM2 RNPS1 BCLAF1 THRAP3 RSRC1 SON | 1.17e-08 | 718 | 41 | 12 | int:DDX21 |
| Interaction | ECT2 interactions | ARL6IP4 BLM ACIN1 SREK1 SRSF2 CHERP SRSF6 SRRM2 RNPS1 BCLAF1 THRAP3 SRSF8 SON | 1.19e-08 | 887 | 41 | 13 | int:ECT2 |
| Interaction | BARD1 interactions | 1.39e-08 | 323 | 41 | 9 | int:BARD1 | |
| Interaction | PRPF40A interactions | 1.55e-08 | 446 | 41 | 10 | int:PRPF40A | |
| Interaction | PAIP1 interactions | 1.66e-08 | 146 | 41 | 7 | int:PAIP1 | |
| Interaction | SIRT7 interactions | BLM ACIN1 SRSF2 CHERP SRSF4 PNN SRRM2 NIPBL PHIP AHCTF1 SON PHRF1 | 1.73e-08 | 744 | 41 | 12 | int:SIRT7 |
| Interaction | RBMX interactions | TRA2A SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SRRM2 RNPS1 CLK3 THRAP3 | 2.11e-08 | 461 | 41 | 10 | int:RBMX |
| Interaction | CCDC9 interactions | 2.32e-08 | 88 | 41 | 6 | int:CCDC9 | |
| Interaction | NCBP3 interactions | 2.62e-08 | 156 | 41 | 7 | int:NCBP3 | |
| Interaction | NKTR interactions | 2.66e-08 | 90 | 41 | 6 | int:NKTR | |
| Interaction | CSNK2B interactions | BLM NKTR CHERP HIRIP3 SRSF6 RNPS1 BCLAF1 THRAP3 RSRC1 CCNL1 PHRF1 | 3.17e-08 | 625 | 41 | 11 | int:CSNK2B |
| Interaction | PRC1 interactions | TRA2A ACIN1 SRSF10 SRSF2 SRSF6 PNN SRRM2 RNPS1 BCLAF1 PHIP THRAP3 SRSF8 SON | 3.57e-08 | 973 | 41 | 13 | int:PRC1 |
| Interaction | SUZ12 interactions | TRA2A ACIN1 SRSF10 SRSF6 RNPS1 EIF2AK3 BCLAF1 THRAP3 SRSF8 AHCTF1 SON | 4.30e-08 | 644 | 41 | 11 | int:SUZ12 |
| Interaction | ZC3H14 interactions | 4.55e-08 | 169 | 41 | 7 | int:ZC3H14 | |
| Interaction | AKAP17A interactions | 4.72e-08 | 99 | 41 | 6 | int:AKAP17A | |
| Interaction | SRSF10 interactions | 6.27e-08 | 271 | 41 | 8 | int:SRSF10 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.60e-12 | 12 | 25 | 5 | 737 | |
| GeneFamily | RNA binding motif containing | 1.15e-08 | 213 | 25 | 7 | 725 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.53e-06 | 22 | 25 | 3 | 579 | |
| GeneFamily | ASAP complex|SIN3 histone deacetylase complex | 5.50e-06 | 3 | 25 | 2 | 1236 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | TRA2A RSRP1 TMEM131 NKTR SRSF2 SRSF4 PNN SRRM2 CLK3 DMAP1 CCNL1 | 2.49e-09 | 634 | 41 | 11 | M40866 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 6.75e-09 | 166 | 41 | 7 | M8129 | |
| Coexpression | FISCHER_DREAM_TARGETS | BLM SRSF10 SRSF2 HIRIP3 PNN RNPS1 EIF2AK3 NIPBL BCLAF1 THRAP3 AHCTF1 RSRC1 | 1.79e-08 | 969 | 41 | 12 | M149 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.81e-08 | 432 | 41 | 9 | M41149 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | ARL6IP4 ACIN1 RSRP1 SRSF2 SRSF6 PNN SRRM2 NIPBL THRAP3 CCNL1 SON ZRANB2 | 1.10e-07 | 1144 | 41 | 12 | MM3843 |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 4.04e-07 | 184 | 41 | 6 | M19988 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 4.63e-07 | 457 | 41 | 8 | M1613 | |
| Coexpression | BENPORATH_CYCLING_GENES | 5.64e-07 | 648 | 41 | 9 | M8156 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 5.73e-07 | 470 | 41 | 8 | MM1053 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 6.10e-07 | 474 | 41 | 8 | M40991 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 6.25e-07 | 656 | 41 | 9 | M18979 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G1_S | 2.02e-06 | 133 | 41 | 5 | M2074 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | BLM TRA2A RSRP1 NKTR SRSF10 SRSF2 CHERP SRSF6 PNN PHIP SRSF8 | 6.67e-06 | 1394 | 41 | 11 | M9585 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | 8.69e-06 | 905 | 41 | 9 | M40865 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.04e-05 | 186 | 41 | 5 | M4911 | |
| Coexpression | GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP | 1.18e-05 | 191 | 41 | 5 | M4926 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TMC8 SRSF10 SRSF2 GPATCH8 PNN NIPBL BCLAF1 PHIP THRAP3 CCNL1 SON | 1.27e-05 | 1492 | 41 | 11 | M40023 |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 1.29e-05 | 335 | 41 | 6 | M10277 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.71e-05 | 32 | 41 | 3 | MM668 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.71e-05 | 32 | 41 | 3 | M1558 | |
| Coexpression | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN | 1.88e-05 | 33 | 41 | 3 | M8981 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.95e-05 | 212 | 41 | 5 | MM3816 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.29e-05 | 776 | 41 | 8 | M1107 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | 2.70e-05 | 794 | 41 | 8 | MM982 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 3.43e-05 | 399 | 41 | 6 | M41172 | |
| Coexpression | FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL | 4.38e-05 | 251 | 41 | 5 | M41709 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 4.60e-05 | 856 | 41 | 8 | M4500 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 4.98e-05 | 1129 | 41 | 9 | M42508 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | 6.06e-05 | 1158 | 41 | 9 | MM1338 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | 8.00e-05 | 680 | 41 | 7 | M41089 | |
| Coexpression | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP | 8.81e-05 | 55 | 41 | 3 | M2180 | |
| Coexpression | BROWNE_HCMV_INFECTION_10HR_DN | 9.80e-05 | 57 | 41 | 3 | M8416 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN | 1.90e-04 | 183 | 41 | 4 | M4289 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 1.96e-04 | 1055 | 41 | 8 | MM3677 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | 2.30e-04 | 807 | 41 | 7 | M14594 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 2.47e-04 | 363 | 41 | 5 | M41103 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.47e-04 | 196 | 41 | 4 | M4244 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 2.47e-04 | 196 | 41 | 4 | M4928 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 2.52e-04 | 197 | 41 | 4 | M5495 | |
| Coexpression | FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL | 2.53e-04 | 365 | 41 | 5 | M41711 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 2.58e-04 | 822 | 41 | 7 | M6782 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 2.59e-04 | 79 | 41 | 3 | M7102 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN | 2.62e-04 | 199 | 41 | 4 | M3738 | |
| Coexpression | GSE3982_DC_VS_BASOPHIL_DN | 2.62e-04 | 199 | 41 | 4 | M5473 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 2.62e-04 | 199 | 41 | 4 | M7607 | |
| Coexpression | GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN | 2.62e-04 | 199 | 41 | 4 | M5726 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 2.62e-04 | 199 | 41 | 4 | M5607 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M5087 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M9449 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP | 2.67e-04 | 200 | 41 | 4 | M8597 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_16H_BMDC_UP | 2.67e-04 | 200 | 41 | 4 | M3950 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 3.55e-04 | 612 | 41 | 6 | MM3804 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 4.03e-04 | 404 | 41 | 5 | M19488 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 4.65e-04 | 644 | 41 | 6 | M41717 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM | 5.41e-04 | 22 | 41 | 2 | M14523 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM | 5.41e-04 | 22 | 41 | 2 | MM676 | |
| Coexpression | HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN | 5.48e-04 | 102 | 41 | 3 | M2124 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | 5.66e-04 | 244 | 41 | 4 | M9945 | |
| Coexpression | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN | 5.92e-04 | 23 | 41 | 2 | M18912 | |
| Coexpression | GARY_CD5_TARGETS_DN | 5.94e-04 | 440 | 41 | 5 | M13893 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | 6.53e-04 | 687 | 41 | 6 | M41022 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP | 7.38e-04 | 113 | 41 | 3 | M1260 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | 7.71e-04 | 265 | 41 | 4 | M19170 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 8.40e-04 | 721 | 41 | 6 | M10237 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | 8.49e-04 | 272 | 41 | 4 | M15123 | |
| Coexpression | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP | 9.22e-04 | 122 | 41 | 3 | M18550 | |
| Coexpression | KAYO_AGING_MUSCLE_DN | 9.66e-04 | 124 | 41 | 3 | M17261 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.06e-03 | 289 | 41 | 4 | M2196 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 1.11e-03 | 130 | 41 | 3 | M6590 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 1.13e-03 | 294 | 41 | 4 | M40873 | |
| Coexpression | DANG_BOUND_BY_MYC | 1.18e-03 | 1061 | 41 | 7 | M15774 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 1.24e-03 | 519 | 41 | 5 | M3395 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TRA2A ACIN1 PNN NIPBL BCLAF1 PHIP THRAP3 AHCTF1 CCNL1 ZRANB2 | 5.00e-08 | 532 | 41 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.36e-07 | 378 | 41 | 8 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.33e-07 | 533 | 41 | 9 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.39e-06 | 429 | 41 | 8 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 2.61e-06 | 819 | 41 | 10 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 3.41e-06 | 844 | 41 | 10 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500 | 6.48e-06 | 241 | 41 | 6 | gudmap_developingGonad_e12.5_testes_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.14e-05 | 406 | 41 | 7 | gudmap_developingGonad_e12.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 2.15e-05 | 822 | 41 | 9 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.22e-05 | 498 | 41 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.81e-05 | 524 | 41 | 7 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.40e-05 | 362 | 41 | 6 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 7.95e-05 | 231 | 41 | 5 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | 9.51e-05 | 1241 | 41 | 10 | facebase_RNAseq_e10.5_MandArch_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BLM TMEM131 SRSF10 SREK1 HIRIP3 PNN NIPBL BCLAF1 THRAP3 AHCTF1 | 1.02e-04 | 1252 | 41 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.06e-04 | 1257 | 41 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_100 | 1.23e-04 | 50 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | 1.46e-04 | 819 | 41 | 8 | gudmap_developingGonad_e16.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.75e-04 | 435 | 41 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.78e-04 | 843 | 41 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.17e-04 | 311 | 41 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 3.57e-04 | 1459 | 41 | 10 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | 3.75e-04 | 1468 | 41 | 10 | facebase_RNAseq_e10.5_MandArch_2500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200 | 3.88e-04 | 179 | 41 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_200 | 4.04e-04 | 181 | 41 | 4 | gudmap_developingGonad_e11.5_testes_200 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.64e-04 | 759 | 41 | 7 | JC_iEC_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 6.23e-04 | 203 | 41 | 4 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_100 | 6.99e-04 | 90 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 7.16e-04 | 790 | 41 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_200 | 7.45e-04 | 92 | 41 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 8.53e-04 | 814 | 41 | 7 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 9.21e-04 | 99 | 41 | 3 | gudmap_developingGonad_e11.5_testes_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.06e-03 | 406 | 41 | 5 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.09e-03 | 105 | 41 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.23e-03 | 629 | 41 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 1.25e-03 | 110 | 41 | 3 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 1.47e-03 | 437 | 41 | 5 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.54e-03 | 259 | 41 | 4 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.76e-03 | 124 | 41 | 3 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.97e-03 | 129 | 41 | 3 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.00e-03 | 469 | 41 | 5 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.18e-03 | 478 | 41 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.29e-03 | 136 | 41 | 3 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_500 | 2.49e-03 | 140 | 41 | 3 | gudmap_developingGonad_e18.5_testes_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.56e-03 | 298 | 41 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ACIN1 NKTR SRSF10 SREK1 PNN SRRM2 NIPBL BCLAF1 PHIP CCNL1 SON ZRANB2 | 3.01e-19 | 200 | 41 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.00e-13 | 188 | 41 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 8.05e-12 | 192 | 41 | 8 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.12e-11 | 200 | 41 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 5.50e-10 | 197 | 41 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.69e-10 | 198 | 41 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.69e-10 | 198 | 41 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.49e-09 | 147 | 41 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.02e-08 | 189 | 41 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.58e-08 | 197 | 41 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.58e-08 | 197 | 41 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.66e-08 | 198 | 41 | 6 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-08 | 199 | 41 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.74e-08 | 199 | 41 | 6 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.20e-07 | 184 | 41 | 5 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.80e-07 | 187 | 41 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-07 | 188 | 41 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.66e-07 | 191 | 41 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-07 | 191 | 41 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.89e-07 | 192 | 41 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.12e-07 | 193 | 41 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 194 | 41 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-07 | 195 | 41 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.84e-07 | 196 | 41 | 5 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.09e-06 | 200 | 41 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Velasco_nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 161 | 41 | 4 | 2de213169fe1965ceaea545297228117c81d9909 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 166 | 41 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 184 | 41 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 187 | 41 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 2.59e-05 | 187 | 41 | 4 | 9000241566f48e435db9409b7255db68b68f6059 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-05 | 189 | 41 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 191 | 41 | 4 | e0072b392f8833fab5e1006148c46a17cce894bc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.88e-05 | 192 | 41 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 193 | 41 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 3.00e-05 | 194 | 41 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 3.00e-05 | 194 | 41 | 4 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 2c03d1a2f208b6737311458a4bd8f2e4444de29a | |
| ToppCell | facs-Skin-Skin_Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | ffd87cc7ae9b141bf48e072ea1a1420794499790 | |
| ToppCell | facs-Skin-Skin_Anagen-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 0d37dd66a8d60fc9cda3d6e3c4fbe67e577b890e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-05 | 196 | 41 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.18e-05 | 197 | 41 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.18e-05 | 197 | 41 | 4 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 3.18e-05 | 197 | 41 | 4 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 3.18e-05 | 197 | 41 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 198 | 41 | 4 | 6b8baa0b76242736f6dba482cdaad019256877ea | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 3.24e-05 | 198 | 41 | 4 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-05 | 198 | 41 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 3.24e-05 | 198 | 41 | 4 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 198 | 41 | 4 | 8519c7bd5f6c5a97f5e43f4729b1411d3b07e4c8 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 3.24e-05 | 198 | 41 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-05 | 198 | 41 | 4 | 33a3b279c9ff3b762e52d060dae062167ca2239b | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 3.31e-05 | 199 | 41 | 4 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-05 | 200 | 41 | 4 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.37e-05 | 200 | 41 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 107 | 41 | 3 | c41bc8810df67158f0ae9f6015c965a8ebd96965 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.31e-04 | 107 | 41 | 3 | 60b272f5c89bea8a2714f870e18b7ac89a4a4bf6 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.59e-04 | 135 | 41 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 153 | 41 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.74e-04 | 153 | 41 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.88e-04 | 155 | 41 | 3 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 3.96e-04 | 156 | 41 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.18e-04 | 159 | 41 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.42e-04 | 162 | 41 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.74e-04 | 166 | 41 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | P15|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.17e-04 | 171 | 41 | 3 | 155e7abd52b84d16146001f6ca49ca0c2294a823 | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-04 | 172 | 41 | 3 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | critical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.35e-04 | 173 | 41 | 3 | 4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 5.72e-04 | 177 | 41 | 3 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 5.81e-04 | 178 | 41 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-04 | 178 | 41 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.91e-04 | 179 | 41 | 3 | db76edd368eeca05a2a5d407c3eb2f535ade0ce3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 6.10e-04 | 181 | 41 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-immature_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.20e-04 | 182 | 41 | 3 | ab78df9de3878a6d67106a40094c893601de8076 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.30e-04 | 183 | 41 | 3 | 62f76907e501bba6e1010b5c447faed5f0ef93a7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 6.50e-04 | 185 | 41 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.81e-04 | 188 | 41 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 6.92e-04 | 189 | 41 | 3 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.92e-04 | 189 | 41 | 3 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-04 | 191 | 41 | 3 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.13e-04 | 191 | 41 | 3 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 7.13e-04 | 191 | 41 | 3 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 7.13e-04 | 191 | 41 | 3 | 12ce360dc149c85d5a22cfc1bf53d54aef79edc1 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-04 | 192 | 41 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-04 | 192 | 41 | 3 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 7.24e-04 | 192 | 41 | 3 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | ILEUM-non-inflamed-(1)_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.24e-04 | 192 | 41 | 3 | a9f89043c97cd2b0ba165e69ee5681094410af37 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 193 | 41 | 3 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 193 | 41 | 3 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature|Fetal_brain / Sample Type, Dataset, Time_group, and Cell type. | 7.35e-04 | 193 | 41 | 3 | 1553c856f3b71c1b0a78ec8d59c7948144d9c5bb | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 7.35e-04 | 193 | 41 | 3 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| Computational | Neighborhood of DDX5 | 3.41e-05 | 63 | 32 | 4 | GNF2_DDX5 | |
| Computational | Neighborhood of DDX5 | 3.86e-05 | 65 | 32 | 4 | GCM_DDX5 | |
| Computational | RNA splicing. | 3.86e-05 | 65 | 32 | 4 | MODULE_183 | |
| Computational | Neighborhood of RAD21 | 1.74e-04 | 37 | 32 | 3 | GCM_RAD21 | |
| Computational | Neighborhood of HDAC1 | 2.99e-04 | 110 | 32 | 4 | GNF2_HDAC1 | |
| Computational | Neighborhood of APEX1 | 3.43e-04 | 114 | 32 | 4 | GCM_APEX1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.27e-04 | 50 | 32 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Neighborhood of SNRP70 | 8.05e-04 | 62 | 32 | 3 | MORF_SNRP70 | |
| Computational | Genes in the cancer module 98. | 9.29e-04 | 393 | 32 | 6 | MODULE_98 | |
| Computational | Neighborhood of BECN1 | 1.05e-03 | 68 | 32 | 3 | GCM_BECN1 | |
| Computational | Genes in the cancer module 198. | 1.86e-03 | 303 | 32 | 5 | MODULE_198 | |
| Drug | AC1NRA5C | TRA2A SRSF10 SREK1 SRSF2 SRSF4 SRSF6 SRRM2 RNPS1 PSKH1 CCNL1 ZRANB2 | 9.78e-15 | 174 | 41 | 11 | CID005287709 |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 7.77e-07 | 179 | 41 | 6 | 4585_DN | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 1.18e-06 | 12 | 41 | 3 | ctd:C578491 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.40e-05 | 172 | 41 | 5 | 1072_DN | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.69e-05 | 179 | 41 | 5 | 331_DN | |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.09e-05 | 187 | 41 | 5 | 3075_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.09e-05 | 187 | 41 | 5 | 4302_DN | |
| Drug | deoxynivalenol | 2.17e-05 | 481 | 41 | 7 | ctd:C007262 | |
| Drug | testosterone enanthate | 6.74e-05 | 575 | 41 | 7 | ctd:C004648 | |
| Drug | Piroxicam | 9.07e-05 | 603 | 41 | 7 | ctd:D010894 | |
| Drug | guanoxan | 1.13e-04 | 9 | 41 | 2 | CID000016564 | |
| Drug | chrysene | 1.38e-04 | 871 | 41 | 8 | ctd:C031180 | |
| Drug | AsF3 | 1.72e-04 | 11 | 41 | 2 | CID000024571 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.19e-04 | 165 | 41 | 4 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.19e-04 | 165 | 41 | 4 | 2835_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.29e-04 | 167 | 41 | 4 | 5217_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.39e-04 | 169 | 41 | 4 | 5572_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.39e-04 | 169 | 41 | 4 | 5231_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.45e-04 | 170 | 41 | 4 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.56e-04 | 172 | 41 | 4 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.62e-04 | 173 | 41 | 4 | 5336_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.68e-04 | 174 | 41 | 4 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.68e-04 | 174 | 41 | 4 | 5693_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.74e-04 | 175 | 41 | 4 | 1014_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.80e-04 | 176 | 41 | 4 | 6932_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.86e-04 | 177 | 41 | 4 | 1645_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.86e-04 | 177 | 41 | 4 | 985_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.86e-04 | 177 | 41 | 4 | 3227_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.86e-04 | 177 | 41 | 4 | 6972_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.92e-04 | 178 | 41 | 4 | 3998_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-04 | 178 | 41 | 4 | 4710_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-04 | 178 | 41 | 4 | 1471_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 178 | 41 | 4 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-04 | 178 | 41 | 4 | 1672_DN | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 2.92e-04 | 178 | 41 | 4 | 579_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 178 | 41 | 4 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-04 | 178 | 41 | 4 | 6276_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.98e-04 | 179 | 41 | 4 | 5822_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.04e-04 | 180 | 41 | 4 | 5981_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.04e-04 | 180 | 41 | 4 | 5511_DN | |
| Drug | benz(a)anthracene | 3.15e-04 | 1251 | 41 | 9 | ctd:C030935 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 3.18e-04 | 182 | 41 | 4 | 1891_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 3.18e-04 | 182 | 41 | 4 | 1951_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A | 3.59e-04 | 188 | 41 | 4 | 345_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.59e-04 | 188 | 41 | 4 | 6735_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 3.81e-04 | 191 | 41 | 4 | 7507_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 7280_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 4361_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 4312_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; HL60; HG-U133A | 4.04e-04 | 194 | 41 | 4 | 1611_DN | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 4.12e-04 | 195 | 41 | 4 | 1138_DN | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; HL60; HG-U133A | 4.12e-04 | 195 | 41 | 4 | 1605_DN | |
| Drug | BW-B 70C; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA | 4.12e-04 | 195 | 41 | 4 | 1132_DN | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 4.20e-04 | 196 | 41 | 4 | 631_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 4.29e-04 | 197 | 41 | 4 | 164_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; HL60; HG-U133A | 4.29e-04 | 197 | 41 | 4 | 1583_UP | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A | 4.37e-04 | 198 | 41 | 4 | 1977_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 5309_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; HL60; HG-U133A | 4.54e-04 | 200 | 41 | 4 | 2018_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HG-U133A | 4.54e-04 | 200 | 41 | 4 | 1952_DN | |
| Drug | trovafloxacin | 5.17e-04 | 371 | 41 | 5 | ctd:C080163 | |
| Drug | Mustard Gas | 5.24e-04 | 1341 | 41 | 9 | ctd:D009151 | |
| Drug | b-Ti | 5.31e-04 | 19 | 41 | 2 | CID011840927 | |
| Drug | F-Ung | 5.35e-04 | 88 | 41 | 3 | CID000125224 | |
| Disease | spermatogenic failure 3 (is_implicated_in) | 1.70e-06 | 2 | 39 | 2 | DOID:0070168 (is_implicated_in) | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.13e-05 | 33 | 39 | 3 | DOID:4467 (is_marker_for) | |
| Disease | Progressive supranuclear palsy | 2.54e-05 | 6 | 39 | 2 | C0038868 | |
| Disease | Ophthalmoplegia, Progressive Supranuclear | 2.54e-05 | 6 | 39 | 2 | C4551862 | |
| Disease | Supranuclear Palsy, Progressive, 1 | 2.54e-05 | 6 | 39 | 2 | C4551863 | |
| Disease | colon adenocarcinoma (is_marker_for) | 5.01e-04 | 25 | 39 | 2 | DOID:234 (is_marker_for) | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.56e-03 | 67 | 39 | 2 | C3463824 | |
| Disease | physical activity | 6.07e-03 | 88 | 39 | 2 | EFO_0003940 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRSRSRSASSNSRKS | 641 | Q9UKV3 | |
| RSRSLSSSGTKHSRQ | 1091 | Q9NZJ5 | |
| CSSASSRSQQSSKRS | 266 | P49761 | |
| KDSKRSRNSRSASRS | 381 | Q9UK58 | |
| KRTTTAASTRRRSAS | 626 | Q6IPM2 | |
| SSKKSSRKGRTRSSS | 386 | Q9BW71 | |
| QKSSSRSSFSHRANR | 456 | Q8IYT1 | |
| KRRKRKNSTSSTSNS | 256 | O43679 | |
| TKSAQSTRSSRSTRS | 386 | P11801 | |
| STRSSRSTRSNKSRR | 391 | P11801 | |
| TKRSSRSSHRSQPSS | 801 | Q9UKJ3 | |
| ARNKTSKSRSRSSSS | 566 | Q9H307 | |
| TSGSLRRSKRNSDST | 2681 | Q6KC79 | |
| SRSRSTSSSRSRKKA | 991 | Q9P1Y6 | |
| RSKAKSRRSSSDRSS | 1046 | Q9P1Y6 | |
| ASQRSKRRKTASSGS | 1341 | P54132 | |
| SRSKSRGRSSSRSNS | 741 | Q8IWX8 | |
| RGRSSSRSNSRSSKS | 746 | Q8IWX8 | |
| RSSKSSGSYSRSRSR | 756 | Q8IWX8 | |
| RSRSRSQSRSRSKSY | 791 | Q8IWX8 | |
| PNSRKRRESASSSSS | 446 | Q9NPF5 | |
| MGRSNSRSHSSRSKS | 1 | Q9NYF8 | |
| SRSHSSRSKSRSQSS | 6 | Q9NYF8 | |
| SRSKSRSQSSSRSRS | 11 | Q9NYF8 | |
| TSSSRKRSFFRSSSS | 216 | P10643 | |
| QKARRRTRSSSSSSS | 66 | Q66PJ3 | |
| ATASFTKSSRSSRTR | 2086 | Q8WYP5 | |
| TKSSRSSRTRSSKAI | 2091 | Q8WYP5 | |
| RSSGSKLSTRNTSRD | 266 | Q13615 | |
| TSRTRSCLKRNASSS | 381 | A6NNC1 | |
| SRTRSCLKRNASSSS | 656 | A6NNC1 | |
| SRKSRSRSGSSKSSH | 201 | Q08170 | |
| SKSSHSKSRSRSRSG | 211 | Q08170 | |
| SKSRSRSRSGSRSRS | 216 | Q08170 | |
| SRSRSKSRSRSQSRS | 226 | Q08170 | |
| SESRSRSKSASKTRS | 456 | Q08170 | |
| RSKSASKTRSRSKSR | 461 | Q08170 | |
| SKTRSRSKSRSRSAS | 466 | Q08170 | |
| SRSRTKSKARSQSVS | 856 | Q12872 | |
| SRTRSRSRSTSKSRS | 151 | Q01130 | |
| RSRSTSKSRSARRSK | 156 | Q01130 | |
| SKSRSARRSKSKSSS | 161 | Q01130 | |
| ARRSKSKSSSVSRSR | 166 | Q01130 | |
| SKSSSVSRSRSRSRS | 171 | Q01130 | |
| KTRKRRSASSGSSST | 61 | Q15287 | |
| SSDTSRSRSRSAAAK | 271 | Q9UQ35 | |
| KNKSRTSQRRSRSNS | 731 | Q9UQ35 | |
| AKRKRRSSSSSSSSS | 2601 | Q9UQ35 | |
| QSYSRGSSRSRTASK | 526 | P30414 | |
| RTASKSSSHSRSRSK | 536 | P30414 | |
| RSAISGFSSKSRRNS | 6 | Q96RN1 | |
| RSRSHTRSKSRSSSK | 191 | Q8WXA9 | |
| TRSKSRSSSKSHSRR | 196 | Q8WXA9 | |
| RSSSKSHSRRKRSQS | 201 | Q8WXA9 | |
| SSRSRSRSISKSRSR | 211 | Q13247 | |
| SRSISKSRSRSRSRS | 216 | Q13247 | |
| SSSARRSKSSSVSRS | 226 | Q9BRL6 | |
| RSKSSSVSRSRSRSR | 231 | Q9BRL6 | |
| SSRSRSRSFSRSSRS | 31 | Q9BUV0 | |
| KSKSGSRSSRSRSAS | 6 | Q9Y2W1 | |
| SRSASRSRSRSFSKS | 16 | Q9Y2W1 | |
| SFSKSRSRSRSLSRS | 26 | Q9Y2W1 | |
| SPRSRSHSRNSDKSS | 136 | Q9Y2W1 | |
| SHSRNSDKSSSDRSR | 141 | Q9Y2W1 | |
| SDRSRRSSSSRSSSN | 151 | Q9Y2W1 | |
| KNSRASSRPFRASSS | 516 | Q8IU68 | |
| RKKRNRSSSVSSSAA | 1441 | Q8WWQ0 | |
| SFSRSKSNSRSRSKS | 171 | O75494 | |
| KSQSRSQSRSRSKSR | 236 | O75494 | |
| SQSRSRSKSRSRSWT | 241 | O75494 | |
| SESHSRSRSKSRSRS | 46 | Q13595 | |
| RAKNSSSTSSRTSAQ | 1236 | Q92545 | |
| SSSSSYGSRRKRSRS | 71 | Q96IZ7 | |
| RSRSKSRSSHSRSSS | 201 | O95218 | |
| SSSRSRSRSRSRSSS | 221 | O95218 | |
| RSRSRSRSSSSSQSR | 226 | O95218 | |
| SSKSKSHRSQTRSRS | 1851 | P18583 |